Andexxa - Andexanet alfa 200 mg / 20mL Injection 20 mL
Reference details for licensed healthcare facility review and verification.
| NDC 11 | 00310-3200-04 |
|---|---|
| Product NDC | 00310-3200 |
| Generic Drug Name | andexanet alfa |
| Brand Name | Andexxa |
| Manufacturer | AstraZeneca Pharmaceuticals LP |
| Strength | 200 mg / 20mL |
| Dosage Form | Injection |
| Drug Type | Intravenous |
| Package Quantity | 4 Vial, Single-Use |
| Package Description | 4 VIAL, SINGLE-USE in 1 CARTON (0310-3200-04) / 20 mL in 1 VIAL, SINGLE-USE (0310-3200-01) |
| Active Ingredients | Andexanet Alfa |
| Marketing Category | BLA |
Unless explicitly stated in writing, no direct affiliation, sponsorship, or endorsement by individual product manufacturers with Premium Rx National, LLC should be implied. All brand names, trade names, and trademarks are the property of their respective owners and are presented solely for accurate product identification and informational reference.
NDC snapshot
andexanet alfa 200 mg / 20mL Injection is tracked under NDC 00310-3200-04 and rolls up into product family 00310-3200. Use this page to review package-level identifiers before comparing related family pages or starting a quote review.
- Package configuration: 4 Vial, Single-Use.
- Manufacturer: AstraZeneca Pharmaceuticals LP.
- Dosage form: Injection.
- Family size: 2 indexed presentations.
Click a tag to refine the catalog view around this product reference.
Official references
Use official labeling and directory references to confirm presentation details while your team reviews the PRN catalog entry and related sourcing paths.
Alternate presentations in this family
These nearby package-level pages can help healthcare teams compare related packaging or presentation differences inside the same product-NDC family.
Drug Shortage Information
Public FDA sources indicate ANDEXXA was permanently discontinued in the US and commercial sales ended in December 2025.
This section is intended to help healthcare teams review public shortage history and related availability references for this product. Supply conditions can change quickly across manufacturers, distributors, and care settings, and these references may not reflect the latest market status. Premium Rx National does not guarantee completeness or suitability for clinical, operational, or purchasing decisions. Please confirm current availability with FDA, manufacturers, and other authoritative sources before relying on this information.
Andexxa - Andexanet alfa 200 mg / 20mL Injection 20 mL, NDC 00310-3200-04, is a AstraZeneca Pharmaceuticals LP 200 mg / 20mL injection presentation packaged as 4 Vial, Single-Use. Historical public shortage information is available for this product reference.
NDC search formats
- Canonical NDC 11: 00310-3200-04
- Digits-only NDC 11: 00310320004
- Possible 10-digit display formats: 0310-3200-04 (0310320004), 00310-3200-4 (0031032004)
Multiple 10-digit display-format aliases can map to the same stored 11-digit billing NDC, so these are shown as search aliases rather than a single asserted package format.
Helpful product links
- Search by brand name: Andexxa
- NDC 11: 00310-3200-04
- Product family NDC: 00310-3200
- Other package sizes in this family: 5 Vial, Single-Use
- Compare related presentations: Andexxa - Andexanet alfa 200 mg / 20mL Injection 20 mL
- VA classification code: BL500
- VA classification code description: BLOOD DERIVATIVES
- CMOP ID: F0673
- VUID: 4038118